© 2001

Thyroid Cancer

  • H.-J. Biersack
  • F. Grünwald
  • Complete coverage of all available diagnostic tools

  • Includes new therapeutic approaches such as high-dose radioiodine therapy and redifferentiation therapy

  • Features special section on medullary thyroid cancer


Table of contents

  1. Front Matter
    Pages I-XX
  2. Basics

    1. Front Matter
      Pages 1-1
    2. M. R. Carlisle, I. R. McDougall
      Pages 55-67
    3. C. Reiners
      Pages 69-79
  3. Differentiated Thyroid Cancer

    1. Front Matter
      Pages 91-91
    2. M. Dietlein, D. Moka, H. Schicha
      Pages 93-120
    3. C. Puskás, M. Biermann, N. Willich, O. Schober
      Pages 121-129
    4. P.-M. Schumm-Draeger
      Pages 131-138
    5. B. Saller
      Pages 139-151
    6. F. Grünwald
      Pages 181-192
    7. J. H. Risse
      Pages 193-224
    8. C. Reiners, J. Biko, E. P. Demidchik, V. Drozd
      Pages 225-235
  4. Medullary Thyroid Cancer

    1. Front Matter
      Pages 237-237
    2. T. M. Behr, W. Becker
      Pages 251-273

About this book


Thyroid cancer was first described at the end of the eighteenth cen­ tury. For one and a half centuries surgery remained the only effective therapeutic option for this cancer, until in 1946 radioiodine therapy was performed for the first time. Radioiodine therapy was brought to Germany 4 years later, in 1950. In the intervening 50 years, the use of iodine-131 has proved able to cure the cancer and its metastases. Per­ cutaneous radiation therapy had been added to the therapeutic ar­ mamentarium, but even now there is heated debate as to its potential. Suppressive 1-thyroxine supplement is a prerequisite for successful treatment, while cytotoxic drugs are mainly used for palliation. During the past 10 years, various new diagnostic and therapeutic approaches have been introduced. High-dose radioiodine therapy as well as redifferentiation therapy with retinoic acid seem beneficial. Diagnostic procedures such as magnetic resonance imaging (MRI), positron emission tomography (PET), as well as isonitriles (MIBI) 201 and thallium ( Tl), have proved useful for the follow-up of thyroid cancer. Two special issues are also discussed in this book. Iodine supple­ mentation in areas of iodine deficiency has led to a change in pathol­ ogy insofar as papillary thyroid cancer (with a better prognosis) has become more frequent than follicular carcinoma. A special chapter is dedicated to thyroid cancer in Chernobyl children.


Magnetic Resonance Imaging (MRI cancer carcinoma diagnosis epidemiology histopathology hormone hormones imaging magnetic resonance imaging (MRI) molecular biology pathology radiation radiation therapy thyroid hormone

Editors and affiliations

  • H.-J. Biersack
    • 1
  • F. Grünwald
    • 2
  1. 1.Klinik und Poliklinik für NuklearmedizinRheinische Friedrich-Wilhelms-UniversitätBonnGermany
  2. 2.Abteilung für NuklearmedizinUniversität FrankfurtFrankfurt am MainGermany

Bibliographic information

  • Book Title Thyroid Cancer
  • Editors H.-J. Biersack
    F. Grünwald
  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 2001
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Hardcover ISBN 978-3-540-41390-5
  • Softcover ISBN 978-3-662-04612-8
  • eBook ISBN 978-3-662-04610-4
  • Edition Number 1
  • Number of Pages XX, 301
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Oncology
    Nuclear Medicine
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology


RAD Magazine, July, 2006: "This latest edition is packed full of facts, updated references and illustrations ... If your everyday care involves thyroid cancer patients, this book is a must."